175 related articles for article (PubMed ID: 27660473)
1. Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer.
Xian Y; Zhang S; Wang X; Qin J; Wang W; Wu H
Onco Targets Ther; 2016; 9():5553-60. PubMed ID: 27660473
[TBL] [Abstract][Full Text] [Related]
2. KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer.
Zhang S; Huang F; Wang Y; Song Q; Yang X; Wu H
Dis Markers; 2016; 2016():7484516. PubMed ID: 27773961
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.
Jia XQ; Zhang S; Zhu HJ; Wang W; Zhu JH; Wang XD; Qiang JF
Transl Oncol; 2016 Jun; 9(3):191-6. PubMed ID: 27267836
[TBL] [Abstract][Full Text] [Related]
4. High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer.
Zhu J; Ma J; Wang X; Ma T; Zhang S; Wang W; Zhou X; Shi J
Transl Oncol; 2016 Dec; 9(6):592-599. PubMed ID: 27916294
[TBL] [Abstract][Full Text] [Related]
5. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
[TBL] [Abstract][Full Text] [Related]
6. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
[TBL] [Abstract][Full Text] [Related]
7. PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer.
Song Z; Feng C; Lu Y; Lin Y; Dong C
Gene; 2018 Feb; 642():43-50. PubMed ID: 29128633
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of phosphoglycerate dehydrogenase in breast cancer.
Chandrika M; Chua PJ; Muniasamy U; Huang RYJ; Thike AA; Ng CT; Tan PH; Yip GW; Bay BH
Breast Cancer Res Treat; 2021 Apr; 186(3):655-665. PubMed ID: 33625616
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment.
Sadiqa A; Rasul A; Hassan M; Sultana S; Jabeen F
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144843
[TBL] [Abstract][Full Text] [Related]
10. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of PHGDH potentiates 5-FU cytotoxicity in gastric cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway.
Zhang Y; Yang L; Dai G; Cao H
Int J Clin Exp Pathol; 2018; 11(12):5869-5876. PubMed ID: 31949673
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
14. Deletion of PHGDH in adipocytes improves glucose intolerance in diet-induced obese mice.
Okabe K; Usui I; Yaku K; Hirabayashi Y; Tobe K; Nakagawa T
Biochem Biophys Res Commun; 2018 Sep; 504(1):309-314. PubMed ID: 30180949
[TBL] [Abstract][Full Text] [Related]
15. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
16. PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
Zhang B; Zheng A; Hydbring P; Ambroise G; Ouchida AT; Goiny M; Vakifahmetoglu-Norberg H; Norberg E
Cell Rep; 2017 Jun; 19(11):2289-2303. PubMed ID: 28614715
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
18. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
[TBL] [Abstract][Full Text] [Related]
19. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
[TBL] [Abstract][Full Text] [Related]
20. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.
Zhao JY; Feng KR; Wang F; Zhang JW; Cheng JF; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2021 May; 217():113379. PubMed ID: 33756126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]